Wednesday 1 August 2012

Tumor Heterogeneity Findings Impact Personalized Medicine Approaches

Tumor Heterogeneity Findings Impact Personalized Medicine Approaches
Extensive renal cancer intratumor heterogeneity identified using Illumina sequencing may explain why biomarker development has been a hit or miss process.



warning slight commercial slant

No comments:

Post a Comment

Datanami, Woe be me